Skip to main content
BCTX
NASDAQ Life Sciences

BriaCell's Bria-IMT Shows Durable Survival, 16.6-Month Median OS in Breast Cancer at ASCO

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$3.28
Mkt Cap
$26.392M
52W Low
$2.98
52W High
$36.9
52W Position info
10% above low
Off High info
91% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

BCTX is trading near its 52-week low of $2.98 (10% above the low).

Summary

BriaCell presented highly positive clinical data for its Bria-IMT immunotherapy at ASCO 2026, reporting a median overall survival of 16.6 months in Phase 2 patients treated with the Phase 3 regimen. The data also showed 50% 12-month and 25% 24-month overall survival rates for patients initiating checkpoint inhibitor therapy in Cycle 1, which is the Phase 3 study regimen. The treatment demonstrated an excellent safety profile with no unexpected signals. This strong clinical progress is crucial for the small-cap biotech, especially following its recent 10-Q that included a going concern warning and a recent dilutive financing. The ongoing pivotal Phase 3 Bria-ABC study will be key for further validation.

At the time of this announcement, BCTX was trading at $3.28 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $26.4M. The 52-week trading range was $2.98 to $36.90. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

BCTX - Latest Insights

BCTX
Oct 28, 2026, 4:43 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $3.50
Real-time Price: $3.40 info
Change: -$0.100 (-3%) info
Market Cap: $28.642M info
BCTX
Jun 26, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.06
Real-time Price: $3.40 info
Change: +$0.340 (+11%) info
Market Cap: $28.642M info
BCTX
Jun 25, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.33
Real-time Price: $3.40 info
Change: +$0.070 (+2%) info
Market Cap: $28.642M info
BCTX
Jun 09, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.07
Real-time Price: $3.40 info
Change: +$0.330 (+11%) info
Market Cap: $28.642M info
BCTX
Jun 02, 2026, 9:32 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.37
Real-time Price: $3.40 info
Change: +$0.030 (+0.89%) info
Market Cap: $28.642M info